XML 21 R11.htm IDEA: XBRL DOCUMENT
v3.21.1

Shareholders' Equity | 3 Months Ended
--- | ---
Apr. 04, 2021
Equity [Abstract] |
Shareholders' Equity | Shareholders' Equity Earnings per Share The following table sets forth the computation of basic and diluted earnings per share:
|  |  |  | Three Months Ended
|  |  |  |  |  | April 4, 2021 |  | March 29, 2020
Numerator: |  |  |  |  |  |  |  |
Net income attributable to Sonoco |  |  |  |  |  | $ | 72,297 |  |  | $ | 80,445 |
Denominator: |  |  |  |  |  |  |  |
Weighted average common shares outstanding: |  |  |  |  |  |  |  |
Basic |  |  |  |  |  | 101,046 |  |  | 100,855 |
Dilutive effect of stock-based compensation |  |  |  |  |  | 446 |  |  | 216 |
Diluted |  |  |  |  |  | 101,492 |  |  | 101,071 |
Net income attributable to Sonoco per common share: |  |  |  |  |  |  |  |
Basic |  |  |  |  |  | $ | 0.72 |  |  | $ | 0.80 |
Diluted |  |  |  |  |  | $ | 0.71 |  |  | $ | 0.80 |
Cash dividends |  |  |  |  |  | $ | 0.45 |  |  | $ | 0.43 |
No adjustments were made to "Net income attributable to Sonoco" in the computations of earnings per share. Anti-dilutive Securities Potentially dilutive securities are calculated in accordance with the treasury stock method, which assumes the proceeds from the exercise of all dilutive stock appreciation rights (SARs) are used to repurchase the Company’s common stock. Certain SARs are not dilutive because either the exercise price is greater than the average market price of the stock during the reporting period or assumed repurchases from proceeds from the exercise of the SARs were antidilutive. These SARs may become dilutive in the future if the market price of the Company's common stock appreciates. The average numbers of SARs that were not dilutive and, therefore, not included in the computation of diluted earnings per share during the three-month periods ended April 4, 2021 and March 29, 2020 were as follows:
|  |  |  | Three Months Ended
|  |  |  |  |  | April 4, 2021 |  | March 29, 2020
Anti-dilutive stock appreciation rights |  |  |  |  |  | 427 |  |  | 589 |
Stock Repurchases On February 10, 2016, the Company’s Board of Directors (the "Board") authorized the repurchase of up to 5,000 shares of the Company's common stock. A total of 2,030 shares were purchased in 2016. Since that time and through April 4, 2021, no additional shares have been repurchased under this authorization; accordingly, a total of 2,970 shares remained available for repurchase at April 4, 2021. On April 20, 2021, the Board authorized the replacement of the February 10, 2016 authorization with an authorization to repurchase the Company's common stock in an aggregate amount of up to $350,000. The Company frequently repurchases shares of its common stock to satisfy employee tax withholding obligations in association with certain share-based compensation awards. These repurchases, which are not part of a publicly announced plan or program, totaled 85 shares during the three months ended April 4, 2021, at a cost of $5,051, and 65 shares during the three months ended March 29, 2020, at a cost of $3,938. Dividend Declarations On February 10, 2021, the Board of Directors declared a regular quarterly dividend of $0.45 per share. This dividend was paid on March 10, 2021 to all shareholders of record as of February 24, 2021. On April 21, 2021, the Board of Directors declared a regular quarterly dividend of $0.45 per share. This dividend is payable on June 10, 2021 to all shareholders of record as of May 10, 2021.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration